For this reason, we need to change the definition of AS to include all cases with nephropathy caused by COL4A3, COL4A4, or COL4A5 gene variants and eliminate the disease entity of TBM; this will allow patients to avoid missing the opportunity to start appropriate treatment as early as possible. Here, COL4A4 is linked to kidney disorder.